3305 results

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease

29 Aug 2022

Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.

Author

Panagiotis Xaplanteris

Over 1,000 patients enrolled in landmark SELUTION DeNovo study

14 Mar 2023

Recruitment complete in BEVAR study for on-label use of the Bentley BeGraft peripheral PLUS as a bridging stent

10 Mar 2023

MedAlliance’s SELUTION SLR™ drug-eluting balloon (DEB) receives FDA Investigational Device Exemption (IDE) approval, making it the first limus DEB to be available to US patients

26 May 2022

FDA approves US oriented clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft for treatment of aortic aneurysms CAUTION: Investigational device. Limited by United States law to investigational use.

28 Jun 2023

MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SELUTION4SFA

04 May 2023

Severely retroflexed calcified circumflex artery – Tackled with left distal radial approach!

30 May 2023

Calcified, retroflexed subtotal long occlusion of left circumflex into OM1 successfully intervened after lithotripsy via left distal radial (anatomical) snuffbox approach

Author

Prasanna Sengodan

Catalysing a more equitable workforce in medicine – Women as One - EuroPCR 2022

19 May 2022

Founded in 2019 by Marie-Claude Morice and Roxana Mehran, the mission of Women as One is to promote talent in medicine by providing unique professional opportunities to women physicians. 

Author

Marie-Claude Morice

Author

Roxana Mehran

A short history of the Euro4C Group

16 Jan 2019

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Future directions of drug-coated balloon angioplasty

06 Feb 2025

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Author

Fernando Alfonso

Author

Javier Cuesta

MedAlliance announces enrollment of first Patient in SELUTION SLR LOVE-DEB coronary study

07 Sep 2023

Enrollment completed in SAVE Trial with SELUTION SLR for treatment of AV fistulas in renal dialysis patients

14 Aug 2023

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)

02 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author

Alessandro Sticchi

Minimally invasive vs conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

07 Mar 2023

Reported from ACC 2023 / WCC

Edoardo Zancanaro provides his take on this clinical trial presented by Enoch Akowuah at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author

Edoardo Zancanaro

Effective techniques for performing DCB angioplasty

16 Jan 2025

Drug-coated balloon (DCB) angioplasty has become a valuable alternative to drug-eluting stents in treating coronary artery disease. To achieve optimal outcomes, proper lesion preparation and techniques to minimise drug loss are crucial.

This article highlights key steps and best practices for performing DCB angioplasty, ensuring effective drug delivery and...

Author

Valeria Paradies

Author

Gianluca Mincione

Extended clopidogrel monotherapy versus DAPT in high-risk patients: The OPT-BIRISK trial

29 Aug 2023

Nicola Ryan provides her take on the final results of OPT-BIRISK which were presented by Yaling Han during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation alone as the trial has not yet been published.

Author

Nicola Ryan

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia

Author

Jorge Sanz-Sanchez

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller